Immunocapture enzyme activity assay
The Ostase® BAP EIA Assay is an in-vitro device indicated for the quantitative measurement of bone-specific alkaline phosphatase (BAP), an indicator of osteoblastic activity in human serum. This device is intended to be used as an aid in the management of postmenopausal osteoporosis and Paget’s disease. Ostase® is a registered trademark of Hybritech Incorporated, a subsidiary of Beckman Coulter, Inc.
Serum levels of BAP are believed to reflect the metabolic status of osteoblasts. An accurate assessment of bone metabolism is critical for determining the severity of metabolic bone disease and responses to therapy. Measurement of serum levels of BAP has been shown to be useful in evaluating patients with Paget’s disease, osteomalacia, primary hyperparathyroidism, renal osteodystrophy, osteoporosis and metastases to bone.
Store the complete kit at 2-8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).
The kits are CE-IVD certified and intended for professional use.